Development of a questionnaire module to supplement the EORTC QLQ-C30 to assess quality of life in patients with hepatocellular carcinoma, the EORTC QLQ-HCC18
- 30 November 2004
- journal article
- research article
- Published by Elsevier BV in European Journal of Cancer
- Vol. 40 (16), 2439-2444
- https://doi.org/10.1016/j.ejca.2004.06.033
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Quality of life in patients diagnosed with primary hepatocellular carcinoma: Hepatic arterial infusion of Cisplatin versus 90‐Yttrium microspheres (Therasphere®)Psycho‐Oncology, 2003
- Hepatocellular CarcinomaJournal of Clinical Gastroenterology, 2002
- A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinomaHepatology, 2002
- Prognostic prediction and treatment strategy in hepatocellular carcinomaHepatology, 2002
- Survival, Functional Limitations, and Self-rated Health in the NHANES I Epidemiologic Follow-up Study, 1992American Journal of Epidemiology, 2000
- Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancerEuropean Journal of Cancer, 1999
- Survival of patients with primary liver cancer, pancreatic cancer and biliary tract cancer in EuropeEuropean Journal of Cancer, 1998
- Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancerEuropean Journal of Cancer, 1996
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- Estimates of the worldwide frequency of sixteen major cancers in 1980International Journal of Cancer, 1988